AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
This Quarter Return
+53.48%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$1.08B
AUM Growth
+$1.08B
Cap. Flow
-$85.3M
Cap. Flow %
-7.87%
Top 10 Hldgs %
96.51%
Holding
17
New
1
Increased
–
Reduced
7
Closed
1

Top Buys

1
QTTB icon
Q32 Bio
QTTB
$35.6M

Top Sells

1
DYN icon
Dyne Therapeutics
DYN
$53M
2
DAWN icon
Day One Biopharmaceuticals
DAWN
$19.5M
3
KYMR icon
Kymera Therapeutics
KYMR
$19.3M
4
IRON icon
Disc Medicine
IRON
$16.7M
5
AKRO icon
Akero Therapeutics
AKRO
$8.39M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DYN icon
1
Dyne Therapeutics
DYN
$1.92B
$228M 21.01%
8,020,136
-1,865,313
-19% -$53M
KYMR icon
2
Kymera Therapeutics
KYMR
$2.95B
$216M 19.95%
5,377,362
-480,900
-8% -$19.3M
IRON icon
3
Disc Medicine
IRON
$2.07B
$142M 13.14%
2,287,233
-267,939
-10% -$16.7M
DAWN icon
4
Day One Biopharmaceuticals
DAWN
$769M
$106M 9.8%
6,430,257
-1,178,137
-15% -$19.5M
THRD
5
DELISTED
Third Harmonic Bio
THRD
$103M 9.5%
10,907,859
– –
KRRO icon
6
Korro Bio
KRRO
$217M
$101M 9.3%
1,119,292
– –
JBIO
7
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$60.3M 5.57%
2,039,249
– –
QTTB icon
8
Q32 Bio
QTTB
$20.9M
$35.6M 3.29%
+2,092,106
New +$35.6M
GBIO icon
9
Generation Bio
GBIO
$40.4M
$33.7M 3.11%
8,279,484
– –
VIGL
10
DELISTED
Vigil Neuroscience
VIGL
$19.9M 1.84%
5,836,874
– –
REPL icon
11
Replimune Group
REPL
$422M
$17.1M 1.58%
2,098,300
– –
IMA
12
ImageneBio, Inc. Common Stock
IMA
$150M
$7.13M 0.66%
5,018,178
– –
TECX
13
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$5.81M 0.54%
4,541,381
– –
DNTH icon
14
Dianthus Therapeutics
DNTH
$759M
$5.61M 0.52%
186,979
-50,000
-21% -$1.5M
XLO icon
15
Xilio Therapeutics
XLO
$36.3M
$1.07M 0.1%
992,912
-1,766,432
-64% -$1.91M
SPRO icon
16
Spero Therapeutics
SPRO
$116M
$1.05M 0.1%
607,613
-405,825
-40% -$698K
AKRO icon
17
Akero Therapeutics
AKRO
$3.74B
– –
-359,251
Closed -$8.39M